Cytosorbents (CTSO) Depreciation & Amortization (CF) (2010 - 2026)
Cytosorbents' (CTSO) quarterly Depreciation & Amortization (CF) came in at $300000.0 in Q1 2026, down 18.59% YoY from $368503.0 in Q1 2025, and up 209.28% on a QoQ basis from $97000.0 in Q4 2025.
Cytosorbents (CTSO) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $300000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 18.59% year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$371000.0 (down 41.88% YoY) and the FY2025 annual result came in at $1.2 million, down 7.57% from the prior year.
- Depreciation & Amortization (CF) advanced to $300000.0 in Q1 2026, from $97000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $407208.0 in Q3 2023 to a low of -$404000.0 in Q2 2025.
- A 5-year average of $123910.4 and a median of $223214.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 91.11% — and 2024, when it tumbled 199.76%.
- Tracing CTSO's Depreciation & Amortization (CF) over 5 years: stood at $223214.0 in 2022, then surged by 75.29% to $391269.0 in 2023, then plunged by 60.64% to $154000.0 in 2024, then plunged by 37.01% to $97000.0 in 2025, then jumped by 209.28% to $300000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $300000.0 (Q1 2026), $97000.0 (Q4 2025), and -$364000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | -351,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -351,000.00 |
| Jun 30, 2026 | -351,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | -364,000.00 |
| Sep 30, 2025 | -364,000.00 |
| Jun 30, 2025 | -404,000.00 |
| Jun 30, 2025 | -404,000.00 |
| Mar 31, 2025 | 368,503.00 |
| Mar 31, 2025 | 368,503.00 |
| Dec 31, 2024 | 154,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | -383,000.00 |
| Sep 30, 2024 | -383,000.00 |
| Jun 30, 2024 | -401,000.00 |
| Jun 30, 2024 | -401,000.00 |
| Mar 31, 2024 | 397,286.00 |
| Mar 31, 2024 | 397,286.00 |